Replies to post #13702 on Delcath Systems Inc (DCTH)

[Zues]

Waiting to get back in @ .05.

Their tests are promising but... too much debt and no FDA approval in the near future. Phase III will be very very expensive not to mention FDA fees for approval post phase III. This stock has more potential for buyout than FDA approval.

GLTY